The NORwegian Atrial Fibrillation Self-SCREENing

NAActive, not recruitingINTERVENTIONAL
Enrollment

50,000

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

Long-term continuous ECG monitoring

Long-term continuous ECG monitoring with ECG247 Smart Heart Sensor

Trial Locations (1)

Unknown

Oslo Unvirsity Hospital, Oslo

All Listed Sponsors
collaborator

Sorlandet Hospital HF

OTHER_GOV

collaborator

Haukeland University Hospital

OTHER

collaborator

St. Olavs Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

lead

Oslo University Hospital

OTHER

NCT05914883 - The NORwegian Atrial Fibrillation Self-SCREENing | Biotech Hunter | Biotech Hunter